Accessibility Statement Skip Navigation
  • Torna ai siti globali
  • +44 (0)20 7454 5110
  • GDPR
  • Giornalisti
  • Richiedi maggiori informazioni
PR Newswire: news distribution, targeting and monitoring
  • Notizie
  • Prodotti
  • Contatto
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Richiedi maggiori informazioni
    • Telefono

    • +44 (0)20 7454 5110 da 8 AM - 5 PM GMT

    • Contattaci
    • Contattaci

      +44 (0)20 7454 5110
      da 8 AM - 5 PM GMT

Close menu
  • Notizie
  • Prodotti
  • Contatto
    • Richiedi maggiori informazioni
    • Giornalisti
    • GDPR
    • General Enquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnership
    • Media Enquiries
    • Worldwide Offices
    • Richiedi maggiori informazioni
    • Giornalisti
    • GDPR

    Lost childhood: a 'tight-knit' network to combat abuse and distress

    MENARINI Group Logo

    Notizia fornita da

    Menarini Industrie Farmaceutiche Riunite

    07 dic, 2022, 11:28 GMT

    Condividi articolo

    Condividi articolo


    On Radar takes off, the first meeting of the Think Tank of Fondazione Internazionale Menarini

    ROME, Dec. 7, 2022 /PRNewswire/ -- Setting real changes in motion through dialogue among experts in order to tackle the unresolved issues of juvenile distress. This was the topic addressed during the first meeting of the 'On Radar' Think Tank of Fondazione Internazionale Menarini held in Rome on November 29th.

    "We believe that a company has the obligation to be part of the social fabric and to encourage dialogue even on the most neglected topics" stated Lucia Aleotti, shareholder and board member of Menarini Group.

    Continue Reading
    First meeting of On Radar, Think Tank of Fondazione Internazionale Menarini
    First meeting of On Radar, Think Tank of Fondazione Internazionale Menarini
    On Radar Logo
    On Radar Logo

    On Radar was born with the aim of observing society, identifying problems and committing to improve the environment in which we live. For its first event, 28 experts were involved, including paediatricians, psychologists, teachers, magistrates and officers of the Italian police force: all brought together to find concrete solutions to the phenomenon of abuse and violence against children and adolescents, which for years now has taken on the proportions of a social scourge all over the world.

    The working tables addressed the problem of child abuse in its various forms of physical and psychological ill-treatment, social isolation and poverty, with special focus on the suburban areas of cities.

    One the proposals that emerged is the creation of a permanent Observatory on abuse care of the Judicial organs with periodic update meetings and the promotion of a network connecting public prosecutors' offices and operators in the sector, to foster dialogue and ensure that individual situations are properly dealt with. But that's not all: involving paediatricians was one of the topics discussed, in order to introduce potential indicators of distress in the drafting of the healthcare report, and the possible role of training courses for new mothers on the risk of disclosing photos of their children on social media, as they might become subject of child pornography. 

    In Italy there are about 9 million minors and of these 9% suffers from abuse, 85% of which is psychological, 10% physical and 3% sexual. Alarming data aggravated by the outbreak of the pandemic.

    "Our ambitious intent," declared Massimo Scaccabarozzi, president of On Radar "is to contribute to achieving a global condition of children's health, in line with some of the goals of the UN's 2030 Agenda, including, in particular, overcoming poverty and access to education".

    Photo - https://mma.prnewswire.com/media/1963436/Menarini_Industrie.jpg
    Logo - https://mma.prnewswire.com/media/1958938/MENARINI_GROUP_Logo.jpg
    Logo - https://mma.prnewswire.com/media/1963434/On_Radar_Logo.jpg

    Modal title

    Also from this source

    Il Gruppo Menarini e Ryvu Therapeutics annunciano i primi dati clinici dello studio di Fase II JASPIS-01 su dapolsertib (MEN1703, SEL24) nel linfoma non Hodgkin aggressivo a cellule B pesantemente pretrattato, recidivato o refrattario, alla riunione annuale dell'ASH del 2026

    Il Gruppo Menarini e Ryvu Therapeutics annunciano i primi dati clinici dello studio di Fase II JASPIS-01 su dapolsertib (MEN1703, SEL24) nel linfoma non Hodgkin aggressivo a cellule B pesantemente pretrattato, recidivato o refrattario, alla riunione annuale dell'ASH del 2026

    Il Gruppo Menarini ("Menarini"), società farmaceutica e diagnostica leader a livello internazionale, e Stemline Therapeutics, Inc. ("Stemline"), una...

    Georgiamune e il Gruppo Menarini sottoscrivono un accordo mondiale esclusivo di licenza e di collaborazione per GIM-621, un agente immuno-oncologico orale innovativo

    Georgiamune e il Gruppo Menarini sottoscrivono un accordo mondiale esclusivo di licenza e di collaborazione per GIM-621, un agente immuno-oncologico orale innovativo

    Il Gruppo Menarini ("Menarini"), società farmaceutica e diagnostica leader a livello internazionale, e Stemline Therapeutics, Inc. ("Stemline"), una...

    More Releases From This Source

    Contatta PR Newswire

    • +44 (0)20 7454 5110
      da 8 AM - 5 PM GMT

    Siti globali

    • APAC
    • APAC - Cinese tradizionale
    • Asia
    • Brasile
    • Canada
    • Ceco
    • Danimarca
    • Finlandia
    • Francia
    • Germania

     

    • India
    • Indonesia
    • Israele
    • Italia
    • Messico
    • Medio Oriente
    • Medio Oriente - Arabo
    • Olanda
    • Norvegia
    • Polonia

     

    • Portogallo
    • Russia
    • Slovacchia
    • Spagna
    • Svezia
    • Regno Unito
    • Stati Uniti

    Do not sell or share my personal information:

    • Submit via [email protected] 
    • Call Privacy toll-free: 877-297-8921
    Siti globali
    • Asia
    • Brasile
    • Canada
    • Ceco
    • Danimarca
    • Finlandia
    • Francia
    • Germania
    • India
    • Israele
    • Italia
    • Messico
    • Medio Oriente
    • Olanda
    • Norvegia
    • Polonia
    • Portogallo
    • Russia
    • Slovacchia
    • Spagna
    • Svezia
    • Regno Uniti
    • Stati Uniti
    +44 (0)20 7454 5110
    da 8 AM - 5 PM GMT
    • Terms of Use
    • Privacy Policy
    • Information Security Policy
    • Site Map
    • Cookie Settings
    Copyright © 2026 Cision US Inc.